Unconventional myosin-Ib
Unconventional myosin-Ib (911-919) is a synthetic peptide fragment derived from the C-terminal region of the myosin-Ib protein, a member of the unconventional myosin superfamily. This peptide encompasses amino acid residues 911 to 919, a segment implicated in protein-protein interactions and regulatory functions within the actin cytoskeleton. As a tool compound, the fragment is valued for its ability to mimic specific linear epitopes of myosin-Ib, providing researchers with a precise molecular probe to investigate the structural and functional dynamics of this motor protein in cellular processes. The unique sequence and biochemical properties of the peptide make it particularly suitable for studies focused on cytoskeletal regulation, intracellular transport, and the mechanistic dissection of unconventional myosin signaling pathways.
Epitope mapping: Researchers employ the 911-919 peptide fragment for the identification and characterization of antibody binding sites within myosin-Ib. By serving as a defined linear epitope, the peptide facilitates the development and validation of monoclonal and polyclonal antibodies targeting this region. Such antibodies are instrumental in immunodetection assays, immunoprecipitation, and localization studies, enabling precise mapping of antigenic determinants and advancing the specificity of immunological reagents used in cytoskeletal research.
Protein-protein interaction studies: The peptide is widely utilized as a molecular probe to elucidate binding interfaces between myosin-Ib and its interacting partners. By incorporating the fragment into pulldown assays or surface plasmon resonance experiments, investigators can assess direct binding affinities, competitive inhibition, and the structural determinants underlying specific protein associations. This approach provides valuable insights into the regulatory mechanisms that govern actin-myosin dynamics and intracellular transport processes.
Peptide competition assays: In functional assays designed to study myosin-Ib activity, the 911-919 peptide can be introduced as a competitive inhibitor to disrupt endogenous interactions involving the native protein. By selectively blocking the binding of full-length myosin-Ib to its partners, the peptide enables researchers to dissect the contribution of the C-terminal region to cellular processes such as membrane trafficking, signal transduction, or cytoskeletal organization. Such experiments help clarify the mechanistic roles of discrete myosin-Ib domains in cellular physiology.
Phosphorylation site analysis: The defined sequence of the peptide fragment allows for targeted investigation of post-translational modifications, particularly phosphorylation events occurring within the C-terminal tail of myosin-Ib. Synthetic peptides corresponding to this region are commonly used as substrates in kinase assays or as calibration standards in mass spectrometry-based phosphoproteomics. These applications enable detailed mapping of regulatory phosphorylation sites, supporting the study of signal-dependent modulation of myosin-Ib activity.
Structural and conformational studies: The 911-919 peptide serves as a model system for examining the secondary structure and conformational flexibility of myosin-Ib's C-terminal tail. Researchers employ spectroscopic techniques such as circular dichroism or nuclear magnetic resonance to analyze the peptide in isolation or in the presence of binding partners. Such studies provide foundational data on the structural motifs and dynamic properties that contribute to the protein's functional versatility, informing broader investigations into unconventional myosin biology.
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More